iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding iSpecimen Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 14 | 15 | +1 |
| Shares | 372.8K | 473.1K | +100.2K (+26.9%) |
| Value | $813.0K | $781.0K | −$32.0K (−3.9%) |
New holders (2)
Institutions that held iSpecimen Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 10,676 | $18.0K | 0.00% |
| GHP Investment Advisors, Inc. | 37 | $0 | 0.00% |
Sold out (1)
Institutions that held iSpecimen Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 19,799 | $43.0K |